Knight Therapeutics Inc
TSX:GUD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
CA |
|
C
|
Circa Group AS
OSE:CIRCA
|
NO |
|
B
|
Bergenbio ASA
OSE:BGBIO
|
NO |
|
M
|
Multibax PCL
SET:MBAX
|
TH |
|
Millennium Pharmacon International Tbk PT
IDX:SDPC
|
ID |
|
I
|
Inuvo Inc
AMEX:INUV
|
US |
|
G
|
Great Wall Terroir Holdings Ltd
HKEX:524
|
HK |
|
Essex Property Trust Inc
NYSE:ESS
|
US |
|
Microchip Technology Inc
NASDAQ:MCHP
|
US |
|
P
|
Przedsiebiorstwo Hydrauliki Silowej Hydrotor SA
WSE:HDR
|
PL |
|
A
|
Answear.Com SA
WSE:ANR
|
PL |
|
M
|
Moolec Science SA
NASDAQ:MLEC
|
LU |
|
ICL Group Ltd
TASE:ICL
|
IL |
|
Nova Eye Medical Ltd
ASX:EYE
|
AU |
|
E
|
Eonmetall Group Bhd
KLSE:EMETALL
|
MY |
|
Amiyaki Tei Co Ltd
TSE:2753
|
JP |
|
O
|
Optimi Health Corp
CNSX:OPTI
|
CA |
Profitability Summary
Knight Therapeutics Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
Margins
Earnings Waterfall
Knight Therapeutics Inc
Margins Comparison
Knight Therapeutics Inc Competitors
| Country | Company | Market Cap |
Gross Margin |
Operating Margin |
Net Margin |
||
|---|---|---|---|---|---|---|---|
| CA |
K
|
Knight Therapeutics Inc
TSX:GUD
|
702.3m CAD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
847.5B USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
576.1B USD |
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.3B USD |
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF |
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.5B GBP |
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
156.8B USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.6B USD |
Loading...
|
Loading...
|
Loading...
|
Return on Capital
Return on Capital Comparison
Knight Therapeutics Inc Competitors
| Country | Company | Market Cap | ROE | ROA | ROCE | ROIC | ||
|---|---|---|---|---|---|---|---|---|
| CA |
K
|
Knight Therapeutics Inc
TSX:GUD
|
702.3m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
847.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
576.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
156.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
